Corcept Therapeutics (CORT) Fair Value & DCF

CORT$72.94-0.77 -1.04%
Medical - PharmaceuticalsGrowth Stock
Compare
Market cap$7.98BEnterprise value$8.47BRevenue (TTM)$963.65MMarket position—

Score

66
Bullish
Value
54
Quality
59
Growth
84

Corcept Therapeutics Incorporated (CORT) trades at $72.94 on $7.98B of equity value, with a trailing P/E of 49.27. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.

Corcept Therapeutics (CORT) Fair Value & DCF

CORT price $72.94 -0.77 -1.04%

Ticker
CORT
Price
$72.94
Change
-0.77 -1.04%
Market cap
$7.98B
P/E
49.27
Forward P/E
16.49
Dividend yield
0.00%
Beta
0.45
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Stocklytics score
66
Value
54
Quality
59
Growth
84

Stocklytics score rationale: value 54, quality 59, growth 84.

AI Score 75. Corcept Therapeutics has a strong gross profit margin of approximately 75.6% and a net profit margin of about 16.8%, indicating solid profitability. However, its high price-to-earnings ratio of approximately 52.8 suggests that the stock may be overvalued relative to its earnings, despite a favorable growth outlook as reflected in its revenue growth in recent quarters

Insights · Forecast · Financials · Learn

Stocklytics home · Screener